Bristol-Myers Squibb Company (BMY) To Present Data For Daclatasvir In Multiple Investigational All-Oral Combinations Across Hepatitis C Genotypes At The International Liver Congress
3/24/2014 8:25:18 AM
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that 12 abstracts have been accepted for presentation at The International Liver CongressTM, the 49th annual meeting of the European Association for the Study of the Liver (EASL), in London, April 9 – 13.
Help employers find you! Check out all the jobs and post your resume.
comments powered by